San Francisco, 19 March, Immunoassay Market Size, Share & Trends
Analysis Report By Product (Reagents & Kits, Software & Services), By
Technology (RIA, EIA, Rapid Test), By Application, By End Use, And Segment
Forecasts, 2019 – 2025.
The global immunoassay market size is expected to reach USD 25.41 billion by 2025,
according to a new report by Grand View Research, Inc. It is anticipated to
expand at a CAGR of 5.0% during the forecast period. Extensive usage of
immunoassay techniques for detection of infectious and chronic diseases is the
prime factor driving the growth. In addition, launch of novel products coupled
with rapid technological advancements are anticipated to drive the market. For
instance, Quidel Corporation received CE mark approval in 2018 for its product
Sofia, which is a Quantitative Vitamin D Assay used with Sofia instrument.
Moreover, collaborations and
partnerships among medical device giants are expected to provide new growth
platforms for immunoassay techniques, such as radioimmunoassay, rapid tests,
and enzyme immunoassays among others. For instance, Roche Diagnostics and GE
Healthcare entered into a partnership to develop and market digital clinical
decision systems in January 2018. This partnership aided in improving cancer
and critical care.
Furthermore, automation has
benefits such as efficiency and optimal usage of labor and space in
laboratories. Thus, the immunoassay market is witnessing lucrative growth as
some players are introducing automated laboratory systems, point-of-testing
compact, and portable assay tests. For instance, launch of innovative products
such as compact and portable ichroma II by Boditech Med, Inc., which is an
FDA-approved fluorescence scanning instrument used for influenza screening.
North America held a significant market share in 2018,
attributed to high R&D investments by pharmaceutical and medical device
manufactures and favorable government insurance policies. For instance, in May
2018, a bill was approved by the U.S. congress, as per which an individual can
try unproven medical aids, which includes drugs, medications, and devices, in
case of severe illness.
Access Full Research
Report On Immunoassay Market Analysis:
Further key findings from the report suggest:
·
Reagents and kits accounted for
a significant market share of about 72.0% in 2018, owing to extensive
application of the products
·
Closed-ended systems is
expected witness a profitable CAGR over the forecast period due to associated
advantages, such as sterility, and cheaper rates as compared to open-ended
systems
·
Asia Pacific is anticipated to
witness significant CAGR over the forecast period due to rising healthcare
spending and healthcare investments by many companies
·
Key players operating in the
immunoassay market are Quidel Corporation; Ortho Clinical Diagnostics; Roche
Diagnostics; and Thermo Fisher Scientific, Inc. among others
·
The industry participants
engage in extensive research activities to develop novel immunoassays for
diagnosis of infectious and chronic diseases.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
global immunoassay market on the basis of product, technology, application, end
use, and region:
Immunoassay Product Outlook
(Revenue, USD Million, 2014 - 2025)
·
Reagents & Kits
·
Analyzers/ instruments
o
Open-ended Systems
o
Closed-ended Systems
·
Software & Services
Immunoassay Technology Outlook
(Revenue, USD Million, 2014 - 2025)
·
Radioimmunoassay (RIA)
·
Enzyme Immunoassay (EIA)
o
Chemiluminescence Immunoassays
(CLIA)
o
Fluorescence Immunoassays (FIA)
·
Rapid test
·
Others
Immunoassay Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Therapeutic drug monitoring
·
Oncology
·
Cardiology
·
Endocrinology
·
Infectious disease testing
·
Autoimmune diseases
·
Others
Immunoassay End Use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Hospitals
·
Blood banks
·
Clinical laboratories
·
Pharmaceutical and biotech
companies
·
Academic research centers
·
Others
Immunoassay Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
The U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Italy
o
Spain
o
Belgium
o
Switzerland
o
Netherlands
o
Poland
o
Austria
o
Greece
o
Sweden
o
Turkey
o
Finland
·
Asia Pacific
o
China
o
India
o
Japan
o
Sri Lanka
o
Malaysia
o
Australia
o
New Zealand
o
Thailand
o
Vietnam
o
Singapore
·
Latin America
o
Mexico
o
Brazil
o
Chile
o
Peru
o
Columbia
o
Argentina
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
o
Jordan
o
UAE
o
Qatar
o
Nigeria
o
Egypt
Browse Press
Release of this Report:
www.grandviewresearch.com/press-release/global-immunoassay-market
www.grandviewresearch.com/press-release/global-immunoassay-market
About Grand View
Research
Grand View
Research provides syndicated as well as customized research reports and
consulting services on 46 industries across 25 major countries worldwide. This
U.S.-based market research and consulting company is registered in California
and headquartered in San Francisco. Comprising over 425 analysts and consultants,
the company adds 1200+ market research reports to its extensive database each
year. Supported by an interactive market intelligence platform, the team at
Grand View Research guides Fortune 500 companies and prominent academic
institutes in comprehending the global and regional business environment and
carefully identifying future opportunities.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment